News | March 27, 2013

Vascular Solutions Recalls Guardian II Hemostasis Valves

Class I recall due to risk of air being introduced into device

Guardian II Hemostais Valve, recall

March 27, 2013 — The U.S. Food and Drug Administration (FDA) notified healthcare professionals of a Class I recall of the Vascular Solutions Inc. Guardian II and Guardian II NC Hemostasis Valves, model numbers 8210, 8211, 8215 and 8216. The firm is recalling the product due to a risk that air may be introduced into the device, which may lead to an air embolism. This product may cause serious adverse health consequences, including death.

A list of the recalled lot numbers is available from Vascular Solutions and has been provided to each facility that purchased the affected products. The recalled products were manufactured and distributed from February 2012 to February 2013.

The Guardian II and Guardian II NC hemostasis valves are intended to reduce blood loss during catheterization procedures.

On Feb. 28, 2013, Vascular Solutions sent an urgent medical device recall letter to its customers. The letter described the problem and the product involved in the recall. The firm advised its customers to immediately remove the recalled product from their inventory and secure it.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program.

For more information: www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm345520.htm

 

 


Related Content

News | Hemostasis Management

October 27, 2021 — Teleflex Inc. announced the completion of patient enrollment in a clinical study evaluating the ...

Home October 27, 2021
Home
News | Hemostasis Management

April 21, 2021 — EnsiteVascular announced it received its second U.S. Food and Drug Administration (FDA) market ...

Home April 21, 2021
Home
Feature | Hemostasis Management | Dave Fornell, Editor

While many cardiac and vascular procedures have largely moved to minimally invasive techniques, the size of these ...

Home March 09, 2021
Home
News | Hemostasis Management

February 8, 2021 — Teleflex Inc. said it recently completed its acquisition of Z-Medica LLC, an industry-leading ...

Home February 08, 2021
Home
News | Hemostasis Management

August 29, 2019 – Merit Medical Systems Inc. announced the U.S. commercial launch of the PreludeSync Evo radial ...

Home August 29, 2019
Home
Technology | Hemostasis Management

February 1, 2019 — Merit Medical Systems Inc. announced that the PreludeSync Distal Compression Device is now available ...

Home February 01, 2019
Home
Videos | Hemostasis Management

Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at ...

Home September 27, 2018
Home
News | Hemostasis Management

August 24, 2016 — Whether severe trauma occurs on the battlefield or the highway, saving lives often comes down to ...

Home August 24, 2016
Home
News | Hemostasis Management

January 6, 2016 — The Medicines Company announced Dec. 18 it has entered into a purchase agreement pursuant to which ...

Home January 06, 2016
Home
Subscribe Now